Ronald Jan, MD
Vascular Surgery · Sacramento, CANPI 1114018199
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,941 of the $4,061 with a category attached, or 72.4%. 17 manufacturers reported payments, led by Atricure, Inc. at 52.1% of the total. Reporting peaked in 2022 at $1,354 and has fallen 91.4% since, to $116 in 2025. That places this record below the midpoint for vascular surgery clinicians in CA, where the typical reported total is $3,945.
Across 55 payments — averaging $73.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$2K
- Johnson & Johnson$485
- Novo Nordisk$176
- Davol Inc.$163
- Sanofi$125
- IBSA Pharma Inc.$125
- plus $869 from 11 others
What the payments were for
- Travel & lodging$1,12028%
- Food & beverage$2,94172%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 21 | $2,118 |
| Johnson & Johnson(2 entities) | 12 | $485 |
| Novo Nordisk | 4 | $176 |
| Davol Inc. | 1 | $163 |
| Sanofi | 1 | $125 |
| IBSA Pharma Inc. | 1 | $125 |
| Amarin Pharma, Inc. | 1 | $125 |
| Baxter Healthcare | 2 | $123 |
| Neurocrine Biosciences, Inc. | 1 | $122 |
| Heron Therapeutics, Inc. | 1 | $119 |
| Lilly USA, LLC | 1 | $99 |
| BTG International Inc. | 1 | $88 |
| Pfizer | 1 | $77 |
| Edwards Lifesciences | 2 | $38 |
| Abiomed | 2 | $30 |
| Biotronik Inc. | 1 | $25 |
| Janssen Scientific Affairs, LLC | 2 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNERGY ABLATION SYSTEM$1,376
- ATRICLIP LAA EXCLUSION SYSTEM$924
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$552
- Progel Applicator Spray Tips$163
- Tirosint$125
- JEVTANA$125
- Vascepa$125
- INGREZZA$122
- Zynrelef$119
- XARELTO$118
- Saxenda$118
- RYBREVANT$116
- CARVYKTI$116
How this compares
$4,061 in reported general payments places this provider in the 50th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 14 | $11,350 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $485 | $11,35014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 519 vascular surgery providers in California.
Other vascular surgery in Sacramento
- Misty HumphriesSacramento$159K
- Son DuongFountain Valley$503K
- Venita ChandraPalo Alto$488K
- Sukgu HanLos Angeles$477K
- Leigh Ann ObanionFresno$469K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
- Johnathon RolloLos Angeles$337K
- Melissa LojaFairfield$272K
- Jason LeePalo Alto$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.